About Locus Biosciences
Locus Biosciences is a company based in Raleigh (United States) founded in 2015.. Locus Biosciences has raised $67.33 million across 12 funding rounds from investors including Tencent, Illumina and Hercules Capital. The company has 74 employees as of December 31, 2022. Locus Biosciences has completed 1 acquisition, including EpiBiome. Locus Biosciences offers products and services including LOCUS Platform and LBP-EC01. Locus Biosciences operates in a competitive market with competitors including Beam Therapeutics, Spero Therapeutics, eGenesis, Korro Bio and Editas Medicine, among others.
- Headquarter Raleigh, United States
- Employees 74 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Locus Biosciences, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Locus Biosciences
Locus Biosciences offers a comprehensive portfolio of products and services, including LOCUS Platform and LBP-EC01. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-driven system for designing engineered bacteriophage therapies for infections.
Targets E. coli infections through precision bacteriophage therapeutics.
Unlock access to complete
Unlock access to complete
Funding Insights of Locus Biosciences
Locus Biosciences has successfully raised a total of $67.33M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $23.9 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $23.9M
-
First Round
First Round
(05 Feb 2016)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Grant - Locus Biosciences | Valuation |
investors |
|
| May, 2022 | Amount | Series B - Locus Biosciences | Valuation | Viking Global Investors , Johnson & Johnson Innovation | |
| Oct, 2021 | Amount | Debt – Conventional - Locus Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Locus Biosciences
Locus Biosciences has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, Illumina and Hercules Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage startups are invested in by Artis Ventures.
|
Founded Year | Domain | Location | |
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Locus Biosciences
Locus Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EpiBiome. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small-molecule antibiotics are developed for agriculture and human health.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Locus Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Locus Biosciences Comparisons
Competitors of Locus Biosciences
Locus Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, Spero Therapeutics, eGenesis, Korro Bio and Editas Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed using CRISPR technology.
|
|
| domain | founded_year | HQ Location |
Pleuromutilin antibiotics are developed for MDR infections.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Locus Biosciences
Frequently Asked Questions about Locus Biosciences
When was Locus Biosciences founded?
Locus Biosciences was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Locus Biosciences located?
Locus Biosciences is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Is Locus Biosciences a funded company?
Locus Biosciences is a funded company, having raised a total of $67.33M across 12 funding rounds to date.
How many employees does Locus Biosciences have?
As of Dec 31, 2022, the latest employee count at Locus Biosciences is 74.
What does Locus Biosciences do?
Locus Biosciences was founded in 2015 and is headquartered in Raleigh, United States. Operations focus on the biotechnology sector, where a platform is utilized to design and deliver custom CRISPR-Cas systems targeting specific bacteria. Antimicrobials for infectious diseases are enabled through this approach, alongside therapeutics for inflammatory indications. Research and development activities are centered on advancing precision treatments in these areas.
Who are the top competitors of Locus Biosciences?
Locus Biosciences's top competitors include Spero Therapeutics, eGenesis and Melinta Therapeutics.
What products or services does Locus Biosciences offer?
Locus Biosciences offers LOCUS Platform and LBP-EC01.
How many acquisitions has Locus Biosciences made?
Locus Biosciences has made 1 acquisition, including EpiBiome.
Who are Locus Biosciences's investors?
Locus Biosciences has 9 investors. Key investors include Tencent, Illumina, Hercules Capital, HHS, and NCBiotech.